Abemaciclib/Endocrine Therapy Improves OS in HR+/HER2– Early Breast Cancer
Written by
Cancer Network
Published
0
comments
0
min
Results from the monarchE study showed a statistically significant OS improvement with abemaciclib plus ET for patients with HR+/HER2– early breast cancer.